Survivors of testicular cancer are more likely to develop metabolic syndrome after platinum-based chemotherapy.
An investigation into whether onset or worsening of diabetes causes pancreatic cancer or vice versa was presented at the 2017 European Cancer Congress.
Patients with diabetes showed more early warning signs of heart failure following chemotherapy.
Patients with diabetes had a significantly higher risk of most cancers, but only in the 10 years prior to and in the 3 months after diabetes diagnosis.
Benign brain tumors that have previously been associated with obesity and diabetes are surprisingly less likely to emerge in patients with high blood sugar, according to new research.
Cigarette smoking is more common among survivors of AYA cancer than those without cancer, and smoking is associated with greater comorbidities and poorer general health.
Older women with diabetes and cancer taking metformin saw an increase in survival.
Pioglitazone use correlated with increased rates of bladder cancer across a large population. The risk of developing bladder cancer also increased with higher dose and longer use of the drug.
Type 1 diabetes was associated with differences in the risk for developing several common cancers.
Early cardiovascular events are a risk for survivors of childhood cancer, according to researchers who also advocate for a unified definition of pediatric metabolic syndrome.
For patients with diabetes, poor glycemic control is linked to higher risk of postoperative progression.
Rates of some adverse events are significantly higher for these patients.
Similar rates of recommended processes of diabetes care were observed for both nurse practitioners and primary care physicians, according to a recent study.
A newly discovered tissue- and organ-specific mechanism that when inhibited, reduces tumor growth in mice with diabetes. The approach may be also used to treat other diabetes complications associated with increased blood vessel growth.
Patients with colorectal cancer who also have diabetes experienced more neuropathic symptoms, regardless of cancer treatment.
Patients receiving taxane-based therapy who have had diabetes for more than 5 years may be at a higher risk for neuropathy.
Blood sugar self-monitoring benefits patients with type 2 diabetes even if they are not prescribed insulin.
Risk of heart attack or stroke is similar for treatment with sulfonylureas or insulin, plus metformin, among patients with type 2 diabetes.
Nut consumption is associated with a reduced risk for developing certain types of cancer, but not type 2 diabetes.
Replacing one serving of a sugary drink per day with water, unsweetened tea, or coffee can reduce the risk of developing type 2 diabetes
Patients with type 2 diabetes mellitus who quit smoking see a temporary deterioration in glycemic control that may last up to three years.
The use of statins is associated with a 46% increase in the risk of developing diabetes.
Each hour spent watching television daily increases the risk of developing diabetes by 3.4%.
Egg consumption may reduce the risk of type 2 diabetes.
Women with diabetes may have an increased risk of being diagnosed with advanced breast cancer, according to new study results.
Metformin use is associated with a decreased risk of developing colorectal cancer.
Repeated use of antibiotics may increase people's risk of developing type 2 diabetes by changing their gut flora.
Breast cancer in women with diabetes is more likely to be advanced stage at diagnosis.
An ingredient found in common cough medicine may be able to aid in the treatment of patients with type 2 diabetes.
Allium cepa, an extract found in onion bulbs, may be able to lower high blood glucose as well as total cholesterol levels in diabetes.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|